iGEMDOCK: A Tool for Drug Discovery
Author Information
Author(s): Hsu Kai-Cheng, Chen Yen-Fu, Lin Shen-Rong, Yang Jinn-Moon
Primary Institution: National Chiao Tung University
Hypothesis
Can iGEMDOCK effectively enhance virtual screening and pharmacological interaction analysis in drug discovery?
Conclusion
iGEMDOCK is a valuable tool for drug discovery, providing insights into ligand binding mechanisms and facilitating the identification of lead compounds.
Supporting Evidence
- iGEMDOCK provides biological insights by deriving pharmacological interactions from screening compounds.
- The tool has been validated on three therapeutic protein targets, showing its effectiveness in identifying essential residues for ligand binding.
- iGEMDOCK improves the accuracy of virtual screening by considering pharmacological interactions.
Takeaway
iGEMDOCK helps scientists find new medicines by showing how drugs interact with proteins, making it easier to discover effective treatments.
Methodology
iGEMDOCK integrates various stages of virtual screening, from protein and compound preparation to post-screening analysis, using a graphical interface.
Limitations
The accuracy of docking tools can be limited by incomplete understanding of ligand binding mechanisms.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website